Paper41923902
Enabling point of care optical diagnostics and treatment of oral lesions in resource-limited settings: Preclinical development and evaluation of a low-cost theranostic intraoral device for image-guided photodynamic therapy.
Khan S and 11 others. Biophotonics Discov, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Enabling point of care optical diagnostics and treatment of oral lesions in resource-limited settings: Preclinical development and evaluation of a low-cost theranostic intraoral device for image-guided photodynamic therapy. Papers, record 41923902. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41923902
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Enabling point of care optical diagnostics and treatment of oral lesions in resource-limited settings: Preclinical development and evaluation of a low-cost theranostic intraoral device for image-guided photodynamic therapy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U01 CA279862 | NCI NIH HHS | United States | U01CA279862 | PubMed | NIH RePORTER |
| U54 CA156734 | NCI NIH HHS | United States | U54CA156734 | PubMed | NIH RePORTER |
References87
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35367616 | Clinical evaluation of a mobile, low-cost system for fluorescence guided photodynamic therapy of early oral cancer in India. | Photodiagnosis Photodyn Ther | 2022 | https://conductscience.org/library/papers/35367616 | PubMed |
| 2 | 26415497 | Animal models for photodynamic therapy (PDT). | Biosci Rep | 2015 | https://conductscience.org/library/papers/26415497 | PubMed |
| 3 | 16965130 | Review of tissue simulating phantoms for optical spectroscopy, imaging and dosimetry. | J Biomed Opt | 2006 | https://conductscience.org/library/papers/16965130 | PubMed |
| 4 | 18260154 | Laser-induced autofluorescence spectral ratio reference standard for early discrimination of oral cancer. | Cancer | 2008 | https://conductscience.org/library/papers/18260154 | PubMed |
| 5 | 15695112 | The status of in vivo autofluorescence spectroscopy and imaging for oral oncology. | Oral Oncol | 2005 | https://conductscience.org/library/papers/15695112 | PubMed |
| 6 | 32370118 | Fluorescence Spectroscopy Study of Protoporphyrin IX in Optical Tissue Simulating Liquid Phantoms. | Materials (Basel) | 2020 | https://conductscience.org/library/papers/32370118 | PubMed |
| 7 | 32529817 | Minimal required PDT light dosimetry for nonmuscle invasive bladder cancer. | J Biomed Opt | 2020 | https://conductscience.org/library/papers/32529817 | PubMed |
| 8 | 8611408 | Kinetics and localisation of PpIX fluorescence after topical and systemic ALA application, observed in skin and skin tumours of UVB-treated mice. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8611408 | PubMed |
| 9 | 26587310 | Study of Collagen Birefringence in Different Grades of Oral Squamous Cell Carcinoma Using Picrosirius Red and Polarized Light Microscopy. | Scientifica (Cairo) | 2015 | https://conductscience.org/library/papers/26587310 | PubMed |
| 10 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 11 | 11152812 | Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: pilot results in the breast. | Radiology | 2001 | https://conductscience.org/library/papers/11152812 | PubMed |
| 12 | 25909707 | In vivo evaluation of battery-operated light-emitting diode-based photodynamic therapy efficacy using tumor volume and biomarker expression as endpoints. | J Biomed Opt | 2015 | https://conductscience.org/library/papers/25909707 | PubMed |
| 13 | 24569464 | Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer. | Br J Cancer | 2014 | https://conductscience.org/library/papers/24569464 | PubMed |
| 14 | 16406802 | Fluorescence spectroscopy combined with 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in detecting oral premalignancy. | J Photochem Photobiol B | 2006 | https://conductscience.org/library/papers/16406802 | PubMed |
| 15 | 2544306 | Determination of subcutaneous tumor size in athymic (nude) mice. | Cancer Chemother Pharmacol | 1989 | https://conductscience.org/library/papers/2544306 | PubMed |
| 16 | 38281610 | Combination of vitamin D and photodynamic therapy enhances immune responses in murine models of squamous cell skin cancer. | Photodiagnosis Photodyn Ther | 2024 | https://conductscience.org/library/papers/38281610 | PubMed |
| 17 | 30925276 | 5-aminolevulinic acid photodynamic therapy reduces HPV viral load via autophagy and apoptosis by modulating Ras/Raf/MEK/ERK and PI3K/AKT pathways in HeLa cells. | J Photochem Photobiol B | 2019 | https://conductscience.org/library/papers/30925276 | PubMed |
| 18 | 21798847 | δ-aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancy. | Neuro Oncol | 2011 | https://conductscience.org/library/papers/21798847 | PubMed |
| 19 | 30219626 | The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990-2016. | Lancet Oncol | 2018 | https://conductscience.org/library/papers/30219626 | PubMed |
| 20 | 23686770 | Mechanism of differentiation-enhanced photodynamic therapy for cancer: upregulation of coproporphyrinogen oxidase by C/EBP transcription factors. | Mol Cancer Ther | 2013 | https://conductscience.org/library/papers/23686770 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42535410 | A low-cost handheld device for monitoring cutaneous photosensitivity. | Photochem Photobiol | 2026 | https://conductscience.org/library/papers/42535410 | PubMed |
| 41891964 | Photodynamic therapy: A paradigm shift in overcoming drug‑resistant tuberculosis (Review). | Mol Med Rep | 2026 | https://conductscience.org/library/papers/41891964 | PubMed |
| 41377090 | Imaging protoporphyrin IX photoproduct accumulation as a dosimetry reporter for monitoring photodynamic therapy of oral cancer. | J Biomed Opt | 2025 | https://conductscience.org/library/papers/41377090 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41923902
GET https://conductscience.org/api/papers/v1/41923902/references?page=2